20478 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#2COMPOSITIONS AND METHODS OF TREATING SUBJECTS WITH BRCA1 MUTATION OR DEFICIENCY
#3COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER
#4COMPOSITION FOR PREVENTING HEART DISEASES CAUSED BY PULMONARY HYPERTENSION AND TREATING HEART, AND FUNCTIONAL FORMULATION COMPRISING SAME
#5CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#6METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#7PHARMACEUTICAL COMPOSITIONS OF SPIRONOLACTONE FOR DEEP DERMAL DRUG DELIVERY
#8COMPOSITIONS AND METHODS FOR THE TOPICAL ADMINISTRATION OF SPIRONOLACTONE FOR THE TREATMENT OF CUTANEOUS SIGNS OF EXCESS ANDROGEN AND CHRONIC STRESS RESPONSE
#9TREATMENT OF DISEASES CAUSED BY RNA VIRUSES
#10COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#11TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#12METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION
#13METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION
#14Synergistic combinations of Spironolactone, Finasteride, Dutasteride, and Minoxidil
#15COMBINATION THERAPIES INVOLVING L-ASPARAGINASE
#16BIOMARKER AND DRUG COMBINATIONS FOR HEART FAILURE PREDICTION
#17PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY
#18METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS
#19USE OF ANTIANDROGENS TO TREAT SEPSIS
#20PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#21METHODS FOR TREATING HAIR LOSS AND NAIL BRITTLENESS, FRAGILITY, OR PITTING
#22TRIPTOLIDE LIGNOCERATE, LIPOSOME THEREOF AND PREPARATION METHOD THEREFOR
#23Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors
#24SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#25SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#26CHEWABLE ORAL CONTRACEPTIVE
#27CONTRACEPTIVE METHODS WITH IMPROVED PEARL INDEX
#28CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS
#29Methods of Treating Ascites
#30METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION
#31Promoting Hair Growth and Treatment of Hair Loss or Excessive Hair Shedding
#32COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#33STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF
#34Method of Treating Ascites
#35METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION
#36OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#37METHOD FOR OPTIMIZING DRUG SELECTION
#38STEROID COMPOUND AND CONJUGATE THEREOF
#39METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS
#40CARDIAC STEROID DERIVATIVES
#41COMPOSITIONS AND METHODS FOR IMMUNE HEALTH
#42Treating Cancers with Combinations of Spironolactone and Acylfulvenes
#43COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#44METHODS FOR THE TREATMENT OF OCULAR ROSACEA
#45TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR
#46GYNECOMASTIA AND/OR MASTALGIA TREATMENT
#47Synthetic progestogens and pharmaceutical compositions comprising the same
#48METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION
#49COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#50WITHAFERIN A AND IMMUNE CHECKPOINT BLOCKER COMBINATION THERAPIES
#51MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF A CORONAVIRUS INFECTION
#52PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PANCREATIC CANCER AND BILE DUCT CANCER
#53RADIOACTIVE ANTITUMOR AGENT
#54METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
#55METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#56TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#57WITHANOLIDE-ENRICHED COMPOSITIONS AND METHODS OF USE THEREOF
#58METHODS OF TREATING CANCER
#59COMBINATION THERAPY FOR PATIENTS HAVING ACUTE AND/OR PERSISTENT DYSPNEA
#60WITHANOLIDE-ENRICHED COMPOSITIONS & METHODS OF USE THEREOF
#61BIOMARKER AND DRUG COMBINATIONS FOR HEART FAILURE PREDICTION
#62PI3K INHIBITORS FOR PROTECTION AGAINST GLUCOCORTICOID-INDUCED ATROPHY
#63USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#64SOLID PREPARATION
#65TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION
#66COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#67Synthetic progestogens and pharmaceutical compositions comprising the same
#68COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM
#69COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS
#70Contraceptive methods with improved pearl index
#71HISTONE-ACETYLATION-MODULATING AGENTS FOR THE TREATMENT AND PREVENTION OF ORGAN INJURY
#72COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#73Compositions and methods for deep dermal drug delivery
#74METHODS AND FORMULATIONS FOR TREATING AND PREVENTING LONG HAUL CORONAVIRUS (LONG COVID) SYMPTOMS AND SEQUELAE
#75COMPOSITIONS FOR THE MANAGEMENT OF DEMYELINATING DISORDERS
#76Methods and Compositions for Treatment of Cystic Fibrosis Class I Mutations
#77METHODS OF DETERMINING WHETHER A SUBJECT HAS OR IS AT RISK OF HAVING A CENTRAL SEROUS CHORIORETINOPATHY
#78PHARMACEUTICAL COMPOSITIONS OF SPIRONOLACTONE FOR DEEP DERMAL DRUG DELIVERY
#79TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS
#80COMPOSITIONS AND METHODS FOR THE TOPICAL ADMINISTRATION OF SPIRONOLACTONE FOR THE TREATMENT OF CUTANEOUS SIGNS OF EXCESS ANDROGEN AND CHRONIC STRESS RESPONSE
#81METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION
#82COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#83COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#84NEW TECHNOLOGY TO CONJUGATE THE TACCALONOLIDE MICROTUBULE STABILIZERS WITH LINKERS/PAYLOADS
#85Compounds and their uses for alleviating menopause-associated symptoms
#86Synthetic progestogens and pharmaceutical compositions comprising the same
#87Method for preventing pregnancy
#88COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#89COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#90Compositions comprising extract for mammalian consumption
#91Modified herbal compositions for neuromodulation
#92COMBINATION THERAPY FOR TREATING OR PREVENTING SKIN DAMAGE
#93METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#94Synthetic progestogens and pharmaceutical compositions comprising the same
#95CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#96Synthetic progestogens and pharmaceutical compositions comprising the same
#97Synthetic progestogens and pharmaceutical compositions comprising the same
#98URINATION DISORDER-IMPROVING AGENT
#99Spironolactone Aqueous Compositions
#100COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND SGLT-2 INHIBITOR
#101COMPOSITIONS CONTAINING ANDROGEN RECEPTOR ANTAGONISTS
#102SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE
#103Spironolactone Aqueous Compositions
#104COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#105Industrial process for the preparation of high purity estetrol
#106COMBINATION
#107METHOD FOR PREVENTING HAIR LOSS
#108Synthetic progestogens and pharmaceutical compositions comprising the same
#109CELLULAR SENESCENCE ACTIVATING COMPOUNDS
#110Methods for treating ascites
#111COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER
#112Synthetic progestogens and pharmaceutical compositions comprising the same
#113METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#114CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#115Synthetic progestogens and pharmaceutical compositions comprising the same
#116Pharmaceutical compositions of pimobendan
#117Synthetic progestogens and pharmaceutical compositions comprising the same
#118Anti-Psychotic Composition and Treatment Methods
#119MULTI-STAGE PERSONALIZED LONGEVITY THERAPEUTICS
#120Compositions and methods for deep dermal drug delivery
#121METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#122Therapeutic treatment of microsatellite unstable cancers
#123Combination product containing limonoid compound and biguanide compound
#124COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS
#125Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
#126CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#127NA+/K+ ATPASE INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF METASTASIS
#128SUPPLEMENT THAT ENHANCES INTRACELLULAR CONCENTRATION OF BIOACTIVE MOLECULES THROUGH INHIBITION OF MULTIDRUG RESISTANT (MDR) EFFLUX PUMPS
#129Bone Morphogenetic Protein Pathway Activation, Compositions for Ossification, and Methods Related Thereto
#130Synthetic progestogens and pharmaceutical compositions comprising the same
#131Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response
#132composition, method of preparation and use thereof
#133Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection
#134Spironolactone aqueous compositions
#135COMPOSITIONS FOR TREATING HAIR LOSS
#136Spironolactone aqueous compositions
#137USE OF COMPOUNDS THAT TARGET MINERALOCORTICOID RECEPTORS FOR TREATING COVID-19
#138Methods of treating ascites
#139PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#140Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer
#141Method to mitigate morbidity and mortality in virally induced forms of ACE2 receptor pathology progressing to SARS or ARDS.
#142Synthetic progestogens and pharmaceutical compositions comprising the same
#143IMMEDIATE RELEASE FORMULATION OF A TRIPLE COMBINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS USEFUL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME
#14417beta-heterocyclyl-digitalis like compounds for the treatment of heart failure
#145NEOANTIGENS AND USES THEREOF
#146Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#147Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same
#148Method of Treating Ascites
#149POLYNUCLEOTIDE AGENTS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12) AND METHODS OF USE THEREOF
#150COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#151Synthetic progestogens and pharmaceutical compositions comprising the same
#152TOPICAL COMPOSITIONS FOR STIMULATING HAIR GROWTH
#153Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation
#154COMPOUND AND USE THEREOF
#155COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#156TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#157Compounds and their uses for alleviating menopause-associated symptoms
#158Compounds and their uses for alleviating menopause-associated symptoms
#159METHOD FOR REMOVING UNDIFFERENTIATED PLURIPOTENT STEM CELLS
#160Methods of Treating Ascites
#161METHODS OF SIZING 6B,7B:15B,16B-DIMETHYLENE-3-OXO-17A-PREGN-4-ENE-21,17-CARBOLACTONE PARTICLES AND COMPOSITIONS COMPRISING THE SAME
#162Synthetic progestogens and pharmaceutical compositions comprising the same
#163WITHANOLIDES FOR THE TREATMENT OF CACHEXIA
#164CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#165METHOD OF TREATING EPILEPSY OR EPILEPTIC ENCEPHALOPATHY WITH FENFLURAMINE IN PATIENTS WITHOUT PULMONARY HYPERTENSION
#166Managing Cardiovascular Conditions Associated with Kidney Disease
#167Spironolactone aqueous compositions
#168Methods for treating memory impairment and cognitive dysfunction
#169Pharmaceutical compositions of pimobendan
#170PLANT-BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS
#171METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#172Eplerenone for phenotyping of CYP3A5 enzyme activity in saliva samples
#173Blood cell biomarker for late onset Alzheimer's disease
#174PREVENTION AND TREATMENT OF FLU-TYPE VIRAL INFECTIONS AND RELATED COMPLICATIONS
#175METHODS OF TREATING CANCER
#176APPLICATION OF PHARMACEUTICAL COMPOSITION IN REGULATION OF FIBROBLAST GROWTH
#177PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#178Spironolactone aqueous compositions
#179TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS
#180Methods and compositions for treating schizophrenia and schizoaffective disorders
#181DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF
#182Formulations comprising aldosterone receptor antagonists and treatments using same
#183Citrus seed extract-containing composition, food, drug, and method for producing citrus seed extract-containing composition
#184Palatable oral veterinary compositions
#185Spironolactone aqueous compositions
#186USE OF WITHANIA SOMNIFERA EXTRACT TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES
#187Extract of aerial parts of Maca rich in polyphenols and composition comprising same
#188Certain chemical entities, compositions, and methods
#189TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#190COMPOSITIONS AND METHODS FOR MODULATING PPP2R1A
#191PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME
#192METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS
#193Antiestrogens and/or Aromatase Inhibitors for Use in Treating Obesity and Related Symptoms
#194Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
#195Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#196Milk-Derived Microvesicle Compositions and Related Methods
#197Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases
#198Natural compounds and fibrosis
#199METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#200COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS
#201COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#202COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#203COMBINATION
#204EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS
#205Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#206PROMOTING HAIR GROWTH AND TREATMENT OF HAIR LOSS OR EXCESSIVE HAIR SHEDDING
#207PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME
#208ANTAGONIST OF MINERALOCORTICOID RECEPTOR FOR THE TREATMENT OF OSTEOARTHRITIS
#209Progesterone Receptor Modulators for Use in the Therapy of Uterine Fibroids
#210COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#211SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES
#212Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#213Certain chemical entities, compositions, and methods
#214TOPICAL APPLICATIONS OF WITHAFERIN A
#215Detection and treatment of excessive hair shedding
#216METHOD FOR THE MANAGEMENT OF DYSMENORRHEA AND MENSTRUAL PAIN
#217Salbutamol-containing ophthalmic medicament
#218Therapeutic and method of use
#219TREATMENT AND DIAGNOSIS OF CANCER
#220Pharmaceutical compositions of pimobendan
#221Pharmaceutical compositions of pimobendan
#222Treatments and formulations comprising Torsemide
#223TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION
#224METHODS OF TREATING AUTOPHAGY-ASSOCIATED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS
#225Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
#226Method of treating senescence with multi-stage longevity therapeutics
#227Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
#228EXTRACELLULAR DRUG CONJUGATES TARGETING CD20
#229COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS
#230BUFADIENOLIDE FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
#231INVOLVEMENT OF THE BUFODIENOLIDES IN THE DIAGNOSIS AND TREATMENT OF POST-TRAUMATIC STRESS DISORDER (PTSD)
#232Compositions for treating neurological disorders
#233SNS-595 AND METHODS OF USING THE SAME
#234Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
#235METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION
#236PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#237Compositions and methods for treating HIV-associated neurocognitive disorders
#238Compositions for improved NRF2 activation and methods of their use
#239DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS
#240COMPOSITIONS AND METHODS FOR TREATMENT OF RENAL DISEASE
#241Reducing the reproductive capacity of mammals
#242Milk-derived microvesicle compositions and related methods
#243PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#244COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#245Certain chemical entities, compositions, and methods
#246Withaferin compositions for prevention of aging
#247Methods and compositions for treating pancreatitis
#248Polymer systems and their applications in diagnostics and drug delivery
#249Small molecule therapeutic compounds that reduce the incidence of intracerebral hemorrhage and brain microhemorrhages
#250Cardiac glycosides to reduce pulmonary exacerbations and other adverse events in cystic fibrosis and other related disorders
#251Compositions and methods for inhibiting hair growth
#252Compositions and methods for treating ocular diseases
#253C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof
#254Composition and method for treating congenital cytomegalovirus induced hearing loss
#255SNS-595 AND METHODS OF USING THE SAME
#256ANTIVIRAL COMPOUND AND ANALOGUES THEREOF FOR TREATMENT OR PREVENTION OF FLAVIVIRUS DENGUE/ZIKA INFECTIONS
#257Combination
#258Detection and treatment of excessive hair shedding
#259Spironolactone aqueous compositions
#260Anti-ar agent and radiation therapy for androgen receptor positive cancer
#261Taccalonolide microtubule stabilizers
#262Modulators of ROR-gamma Receptors, Composition and Use Thereof
#263ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR THE MODIFIED RELEASE OF ACTIVE PRINCIPLE(S).
#264INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#265INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#266Pharmaceutical compositions for preventing glucocorticoid-induced corneal thinning
#267Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport
#268Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
#269Methods and compositions for treating alcohol use disorders
#270Treating Various Disorders Using TrkB Agonists
#271Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#272APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS
#273WITHACNISTIN COMPOUNDS FOR TREATMENT OF CANCER
#274CITRUS SEED EXTRACT-CONTAINING COMPOSITION, FOOD, DRUG, AND METHOD FOR PRODUCING CITRUS SEED EXTRACT-CONTAINING COMPOSITION
#275Compositions and methods for disease treatment using nanoparticle delivered compounds
#276Cardiac Glycosides for the Treatment of Hypercholesterolemia
#277Spironolactone aqueous formulations
#278SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancer
#279Method for treating age-related hearing loss (ARHL)
#280EXTRACELLULAR TARGETED DRUG CONJUGATES
#281MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#282COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#283ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment
#284Certain chemical entities, compositions, and methods
#285Topical nanodrug formulation
#286Methods and Compositions for Inhibiting Mitochondrial Trafficking
#287COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF
#288Triptolide derivatives and preparation method and use thereof
#289Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#290Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#291Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer
#292Controlled release fatty acid compositions for use in body reconstruction and body-shaping
#293Inhibitors of the renal outer medullary potassim channel
#294Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds
#295Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#296TACCALONOLIDE MICROTUBULE STABILIZERS
#297Pharmaceutical combinations for the treatment of cancer
#298Treating Various Disorders Using TrkB Agonists
#299Composition comprising torasemide and baclofen for treating neurological disorders
#300COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS